![Christopher Degnan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Degnan
Directeur Financier/CFO chez
UROGEN PHARMA LTD.
Fortune : 87 187 $ au 31/07/2026
Profil
Christopher Degnan currently works at UroGen Pharma Ltd., as Chief Financial & Accounting Officer from 2024.
Mr. Degnan also formerly worked at AstraZeneca PLC, as Senior Finance Director from 2004 to 2014, Endo International Plc, as Chief Financial Officer from 2016 to 2018, Endo Pharmaceuticals, Inc., as Chief Financial Officer & Vice President-Finance, Verrica Pharmaceuticals, Inc., as Chief Financial & Accounting Officer from 2018 to 2019, and Galera Therapeutics, Inc., as Chief Financial & Accounting Officer.
Mr. Degnan received his undergraduate degree from the University of Notre Dame.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/01/2026 | 2 280 ( 0 % ) | 87 187 $ | 31/07/2026 |
Postes actifs de Christopher Degnan
| Sociétés | Poste | Début |
|---|---|---|
| UROGEN PHARMA LTD. | Directeur Financier/CFO | 08/10/2024 |
Anciens postes connus de Christopher Degnan
| Sociétés | Poste | Fin |
|---|---|---|
| GALERA T COM USD0. | Directeur Financier/CFO | 31/08/2024 |
| VERRICA PHARMACEUTICALS INC. | Directeur Financier/CFO | 07/10/2019 |
| ENDO INTERNATIONAL PLC | Directeur Financier/CFO | 01/03/2018 |
| ASTRAZENECA PLC | Directeur Financier/CFO | 01/11/2014 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur Financier/CFO | - |
Formation de Christopher Degnan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
